SCHEMBL3918740

SCHEMBL3918740

C#CNCCN.[LiH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8595598 0.97
Lithium SCHEMBL31125796 0.94
SCHEMBL4459635 0.79
SCHEMBL8374277 0.73 CA12 (0.41)
SCHEMBL23140264 0.71
SCHEMBL16513194 0.65
SCHEMBL11745151 0.65
SCHEMBL209664 0.65
SCHEMBL24245454 0.62
SCHEMBL23322283 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448969-B Refining method of desogestrel 上海格苓凯生物科技有限公司 2024-05-28 CN claimed
CN-114031598-B Preparation method of polysubstituted dibenzochromene compound 江苏视科新材料股份有限公司 2023-07-28 CN claimed
CN-114031599-B Preparation method of dibenzochromene photochromic compound 江苏视科新材料股份有限公司 2023-07-25 CN claimed
CN-115448969-A Refining method of desogestrel 上海格苓凯生物科技有限公司 2022-12-09 CN claimed
CN-112080266-A Compact reservoir composite drying agent for improving salt resistance and preparation method thereof 西南石油大学 2020-12-15 CN claimed
CN-115448969-B Refining method of desogestrel 上海格苓凯生物科技有限公司 2024-05-28 CN disclosed
CN-114031595-B Photochromic compound and application thereof 江苏视科新材料股份有限公司 2024-01-26 CN disclosed
CN-110869355-B Benzopyran compound, curable composition containing the compound, and optical article containing cured product formed from the curable composition 株式会社德山 2023-11-14 CN disclosed
CN-117042769-A Substituted pyrrolopyrimidines and pyrazolopyrimidines as Bruton's Tyrosine Kinase (BTK) degrading agents 冰洲石生物科技公司 2023-11-10 CN disclosed
CN-115999324-B Treatment fluid for VOC-containing organic waste gas and application thereof 苏州艾特斯环保设备有限公司 2023-10-13 CN disclosed
CN-114230601-B Preparation and application of chiral enol compound 上海彩迩文生化科技有限公司 2023-09-22 CN disclosed
CN-116648240-A Cyclic peptide virus protease inhibitor, preparation method thereof and application thereof in antiviral drugs 中国人民解放军军事科学院军事医学研究院 2023-08-25 CN disclosed
CN-1823084-A Methods for preparing 2-alkynyladenosine derivatives BRISTOL MYERS SQUIBB PHARMA CO (US) 2006-08-23 CN disclosed
US-20050107416-A1 17-hydroxy 4-aza androstan -3-ones as androgen receptor modulators MERCK SHARP & DOHME CORP. 2005-05-19 US disclosed
EP-1467739-A2 17-HYDROXY-4-AZA-ANDROSTAN-3-ONES AS ANDROGEN RECEPTOR MODULATORS Merck & Co., Inc. (US) 2004-10-20 EP disclosed
CN-1433424-A 8 beta-hydrocarbyl substituted estratrienes as selectively active estrogens SCHERING AG (DE) 2003-07-30 CN disclosed
WO-2003059293-A2 17-HYDROXY-4-AZA-ANDROSTAN-3-ONES AS ANDROGEN RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-07-24 WO disclosed
CN-1312803-A Novel benzopyran or benzothiopyran derivatives C & C RES LAB (KR) 2001-09-12 CN disclosed
CN-1222159-A 6, 7-oxidized steroids and uses thereof INFLAZYME PHARM LTD (CA) 1999-07-07 CN disclosed
CN-1188471-A 1,4-disubstituted piepridine derivatives BANYU PHARMA CO LTD (JP) 1998-07-22 CN disclosed